Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Comparison of two methods for estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and family history.

Hsu FC, Sun J, Zhu Y, Kim ST, Jin T, Zhang Z, Wiklund F, Kader AK, Zheng SL, Isaacs W, Grönberg H, Xu J.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1083-8. doi: 10.1158/1055-9965.EPI-09-1176. Epub 2010 Mar 23.

2.

Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction.

Agalliu I, Wang Z, Wang T, Dunn A, Parikh H, Myers T, Burk RD, Amundadottir L.

PLoS One. 2013;8(4):e60083. doi: 10.1371/journal.pone.0060083. Epub 2013 Apr 3.

3.

Strategies for developing prediction models from genome-wide association studies.

Wu J, Pfeiffer RM, Gail MH.

Genet Epidemiol. 2013 Dec;37(8):768-77. doi: 10.1002/gepi.21762. Epub 2013 Oct 25.

PMID:
24166696
4.

Predictive performance of prostate cancer risk in Chinese men using 33 reported prostate cancer risk-associated SNPs.

Zheng J, Liu F, Lin X, Wang X, Ding Q, Jiang H, Chen H, Lu D, Jin G, Hsing AW, Shao Q, Qi J, Ye Y, Wang Z, Gao X, Wang G, Chu LW, Ouyang J, Huang Y, Chen Y, Gao Y, Shi R, Wu Q, Wang M, Zhang Z, Hu Y, Sun J, Zheng SL, Gao X, Xu C, Mo Z, Sun Y, Xu J.

Prostate. 2012 Apr;72(5):577-83. doi: 10.1002/pros.21462. Epub 2011 Jul 27.

5.

Known susceptibility SNPs for sporadic prostate cancer show a similar association with "hereditary" prostate cancer.

Cremers RG, Galesloot TE, Aben KK, van Oort IM, Vasen HF, Vermeulen SH, Kiemeney LA.

Prostate. 2015 Apr 1;75(5):474-83. doi: 10.1002/pros.22933. Epub 2015 Jan 5.

PMID:
25560306
6.

Estimation of absolute risk for prostate cancer using genetic markers and family history.

Xu J, Sun J, Kader AK, Lindström S, Wiklund F, Hsu FC, Johansson JE, Zheng SL, Thomas G, Hayes RB, Kraft P, Hunter DJ, Chanock SJ, Isaacs WB, Grönberg H.

Prostate. 2009 Oct 1;69(14):1565-72. doi: 10.1002/pros.21002.

7.

Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.

Fitzgerald LM, Kwon EM, Koopmeiners JS, Salinas CA, Stanford JL, Ostrander EA.

Clin Cancer Res. 2009 May 1;15(9):3231-7. doi: 10.1158/1078-0432.CCR-08-2190. Epub 2009 Apr 14.

8.

Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.

Conran CA, Na R, Chen H, Jiang D, Lin X, Zheng SL, Brendler CB, Xu J.

Asian J Androl. 2016 Jul-Aug;18(4):520-4. doi: 10.4103/1008-682X.179527.

9.

Genetic variants and family history predict prostate cancer similar to prostate-specific antigen.

Zheng SL, Sun J, Wiklund F, Gao Z, Stattin P, Purcell LD, Adami HO, Hsu FC, Zhu Y, Adolfsson J, Johansson JE, Turner AR, Adams TS, Liu W, Duggan D, Carpten JD, Chang BL, Isaacs WB, Xu J, Grönberg H.

Clin Cancer Res. 2009 Feb 1;15(3):1105-11. doi: 10.1158/1078-0432.CCR-08-1743.

10.

Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes.

Ren S, Xu J, Zhou T, Jiang H, Chen H, Liu F, Na R, Zhang L, Wu Y, Sun J, Yang B, Gao X, Zheng SL, Xu C, Ding Q, Sun Y.

Prostate. 2013 Dec;73(16):1824-35. doi: 10.1002/pros.22721. Epub 2013 Aug 26.

11.

A comparison of Bayesian and frequentist approaches to incorporating external information for the prediction of prostate cancer risk.

Newcombe PJ, Reck BH, Sun J, Platek GT, Verzilli C, Kader AK, Kim ST, Hsu FC, Zhang Z, Zheng SL, Mooser VE, Condreay LD, Spraggs CF, Whittaker JC, Rittmaster RS, Xu J.

Genet Epidemiol. 2012 Jan;36(1):71-83. doi: 10.1002/gepi.21600.

12.

Performance of an adipokine pathway-based multilocus genetic risk score for prostate cancer risk prediction.

Ribeiro RJ, Monteiro CP, Azevedo AS, Cunha VF, Ramanakumar AV, Fraga AM, Pina FM, Lopes CM, Medeiros RM, Franco EL.

PLoS One. 2012;7(6):e39236. doi: 10.1371/journal.pone.0039236. Epub 2012 Jun 29.

13.

Replication of prostate cancer risk loci in a Japanese case-control association study.

Yamada H, Penney KL, Takahashi H, Katoh T, Yamano Y, Yamakado M, Kimura T, Kuruma H, Kamata Y, Egawa S, Freedman ML.

J Natl Cancer Inst. 2009 Oct 7;101(19):1330-6. doi: 10.1093/jnci/djp287. Epub 2009 Sep 2.

PMID:
19726753
14.

Clinical utility of five genetic variants for predicting prostate cancer risk and mortality.

Salinas CA, Koopmeiners JS, Kwon EM, FitzGerald L, Lin DW, Ostrander EA, Feng Z, Stanford JL.

Prostate. 2009 Mar 1;69(4):363-72. doi: 10.1002/pros.20887.

15.

Using graded response model for the prediction of prostate cancer risk.

Chen SH, Ip EH, Xu J, Sun J, Hsu FC.

Hum Genet. 2012 Aug;131(8):1327-36. doi: 10.1007/s00439-012-1160-8. Epub 2012 Mar 30.

16.

Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.

Klein RJ, Halldén C, Cronin AM, Ploner A, Wiklund F, Bjartell AS, Stattin P, Xu J, Scardino PT, Offit K, Vickers AJ, Grönberg H, Lilja H.

Cancer Prev Res (Phila). 2010 May;3(5):611-9. doi: 10.1158/1940-6207.CAPR-09-0206. Epub 2010 Apr 27.

17.

Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factors.

Bruzelius M, Bottai M, Sabater-Lleal M, Strawbridge RJ, Bergendal A, Silveira A, Sundström A, Kieler H, Hamsten A, Odeberg J.

J Thromb Haemost. 2015 Feb;13(2):219-27. doi: 10.1111/jth.12808. Epub 2015 Jan 12.

18.

A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.

Kerns SL, Stock R, Stone N, Buckstein M, Shao Y, Campbell C, Rath L, De Ruysscher D, Lammering G, Hixson R, Cesaretti J, Terk M, Ostrer H, Rosenstein BS.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):e21-8. doi: 10.1016/j.ijrobp.2012.08.003. Epub 2012 Sep 26.

19.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

PMID:
17925536
20.

Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations.

Sun J, Chang BL, Isaacs SD, Wiley KE, Wiklund F, Stattin P, Duggan D, Carpten JD, Trock BJ, Partin AW, Walsh PC, Grönberg H, Xu J, Isaacs WB, Zheng SL.

Prostate. 2008 Sep 1;68(12):1257-62. doi: 10.1002/pros.20793.

Supplemental Content

Support Center